HealthBayer Seeks FDA Approval For Regorafenib As Liver Cancer Treatment German drugmaker Bayer on Monday submitted an sNDA proposal to the FDA for the extension of its drug Regorafenib as a second-line treatment for liver cancer. The drug is currently used to treat colorectal cancer.by Alyssa Navarro
HealthPrescription Testosterone, Other Steroid Drugs Product Labels Get New Warning From FDAby Carl Velasco
HealthFDA Issues Safety Warning For St. Jude Medical Implanted Defibrillators After Two Deaths Reportedby Livia Rusu
HealthFDA Warns Against Hepatitis B Reactivation In Some Patients Taking Direct-Acting Hepatitis C Antiviralsby Saranya Palanisamy
HealthUS Allows More Marijuana Research But Rejects Requests To Change Classificationby Alyssa Navarro
South Korea's ICT Exports Hit All-Time Growth Rate of 125.9% in April, Driven by AI Server Chip Demand